The inaugural meeting of the International Alliance for Life Extension Research has received wide attention from the society
Release time:
2023-03-28
On March 28, 2023, the kick-off meeting of the International Alliance for Life Extension Research was held in Yinfeng Biotechnology Park, Jinan, Shandong. The "International Alliance for Life Extension Research" was initiated by Shandong Yinfeng Life Science Research Institute, and jointly established by 13 international scientific research institutions engaged in the field of cryogenic biomedicine from North America, Europe, Oceania, etc.

The conference was hosted by Shandong Yinfeng Life Science Research Institute, co-organized by Shandong Refrigeration Society and Shandong University Advertising Research Center, Counselor of Shandong Provincial Government, Jinan Science and Technology Bureau, Jinan Municipal Health Commission, Jinan High-tech Entrepreneurship Service Center and other relevant leaders, as well as experts from Shandong University, Shandong University Qilu Hospital and other cooperative units attended the conference, and received great attention and attention from leaders at all levels. The official website of the Management Committee of Jinan High-tech Industrial Development Zone and other news media jointly released by People's Daily, China Daily, Jinan Daily and other news media.


The purpose of this conference is to conduct academic exchanges in the field of cryogenic biomedical preservation, focusing on topics such as "scientific and technological innovation" and "future technology", and conducting on-site exchanges. Biostasis Technologies (USA), SOCIÉTÉ CRYONICS DE FRANCE (France), Southern Cryonics and CryoPath (Australia), University of Surrey (UK), Tomorrow Bio / European Biostasis Foundation (Switzerland/Germany), 13 foreign institutions, including the University of Seville (Spain), participated and shared the theme.


Innovation drives development, science and technology create the future. The conference has received the attention of leaders at all levels, which is the support and encouragement of Yinfeng cryogenic medical scientific research work, and the "International Alliance for Life Extension Research" will work together with international cryogenic biomedical research institutions to take the development of biomedical technology for all mankind as its own responsibility, and gradually establish an international cryogenic biomedical research results sharing platform, open a new chapter in the field of international cryogenic biomedical cooperation, and work together for the dream of human life continuation.
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.